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There is a paucity of information about cardiovascular outcomes related to exercise habit
change after a new diagnosis of atrial fibrillation (AF). We investigated the association
between exercise habits after a new AF diagnosis and ischemic stroke, heart failure (HF),
and all-cause death.
Methods and findings
This is a nationwide population-based cohort study using data from the Korea National
Health Insurance Service. A retrospective analysis was performed for 66,692 patients with
newly diagnosed AF between 2010 and 2016 who underwent 2 serial health examinations
within 2 years before and after their AF diagnosis. Individuals were divided into 4 categories
according to performance of regular exercise, which was investigated by a self-reported
questionnaire in each health examination, before and after their AF diagnosis: persistent
non-exercisers (30.5%), new exercisers (17.8%), exercise dropouts (17.4%), and exercise
maintainers (34.2%). The primary outcomes were incidence of ischemic stroke, HF, and all-
cause death. Differences in baseline characteristics among groups were balanced consider-
ing demographics, comorbidities, medications, lifestyle behaviors, and income status. The
risks of the outcomes were computed by weighted Cox proportional hazards models with
inverse probability of treatment weighting (IPTW) during a mean follow-up of 3.4 ± 2.0
years. The new exerciser and exercise maintainer groups were associated with a lower risk
of HF compared to the persistent non-exerciser group: the hazard ratios (HRs) (95% CIs)







Citation: Ahn H-J, Lee S-R, Choi E-K, Han K-D,
Jung J-H, Lim J-H, et al. (2021) Association
between exercise habits and stroke, heart failure,
and mortality in Korean patients with incident atrial
fibrillation: A nationwide population-based cohort
study. PLoS Med 18(6): e1003659. https://doi.org/
10.1371/journal.pmed.1003659
Academic Editor: Kazem Rahimi, University of
Oxford, UNITED KINGDOM
Received: June 30, 2020
Accepted: May 18, 2021
Published: June 8, 2021
Peer Review History: PLOS recognizes the
benefits of transparency in the peer review
process; therefore, we enable the publication of
all of the content of peer review and author
responses alongside final, published articles. The
editorial history of this article is available here:
https://doi.org/10.1371/journal.pmed.1003659
Copyright: © 2021 Ahn et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All relevant data are
within the manuscript and its Supporting
Information files.
were 0.95 (0.90–0.99) and 0.92 (0.88–0.96), respectively (p < 0.001). Also, performing exer-
cise any time before or after AF diagnosis was associated with a lower risk of mortality com-
pared to persistent non-exercising: the HR (95% CI) was 0.82 (0.73–0.91) for new
exercisers, 0.83 (0.74–0.93) for exercise dropouts, and 0.61 (0.55–0.67) for exercise main-
tainers (p < 0.001). For ischemic stroke, the estimates of HRs were 10%–14% lower in
patients of the exercise groups, yet differences were statistically insignificant (p = 0.057).
Energy expenditure of 1,000–1,499 MET-min/wk (regular moderate exercise 170–240 min/
wk) was consistently associated with a lower risk of each outcome based on a subgroup
analysis of the new exerciser group. Study limitations include recall bias introduced due to
the nature of the self-reported questionnaire and restricted external generalizability to other
ethnic groups.
Conclusions
Initiating or continuing regular exercise after AF diagnosis was associated with lower risks of
HF and mortality. The promotion of exercise might reduce the future risk of adverse out-
comes in patients with AF.
Author summary
Why was this study done?
• Atrial fibrillation (AF) is associated with an increased risk of stroke, heart failure, and
death. As AF and its related healthcare burden are expected to surge, integrated man-
agement of AF is advocated as part of holistic care.
• Exercise has been established to benefit AF-related outcomes, including symptoms, inci-
dence, recurrence, burden, and quality of life. However, there are no current data pro-
viding the association between exercise and cardiovascular morbidities in patients with
AF.
What did the researchers do and find?
• We performed a retrospective analysis of 66,692 patients with newly diagnosed AF who
underwent 2 serial health examinations before and after their AF diagnosis from 2010 to
2016 using data from the Korea National Health Insurance Service.
• Individuals self-reported exercise status by a questionnaire included in each health
examination and were categorized into 4 groups according to their change of exercise
status from before to after their AF diagnosis. We investigated and compared the inci-
dences of ischemic stroke, heart failure, and all-cause death across the groups.
• Initiating or continuing regular exercise after a diagnosis of AF was associated with a
5%–8% lower risk of HF and 17%–39% lower risk of mortality than being a persistent
non-exerciser. For ischemic stroke, the estimated hazard ratios were 10%–14% lower in
patients in the exercise group, yet statistical significance was undetermined.
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What do these findings mean?
• We suggest the potential benefits of exercise as a lifestyle intervention for cardiovascular
outcomes in AF patients by demonstrating the association. The promotion of exercise
might reduce the future risk of adverse outcomes in patients with AF.
Introduction
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, and the prevalence
has been continuously growing over the past decades, potentially due to aging and an increase
of risk factors predisposing to AF [1–3]. The clinical implication of AF is that it is associated
with an increased risk of stroke, heart failure (HF), myocardial infarction (MI), and death
[2,4]. As AF and its related healthcare burden are expected to surge in the coming years [5],
this common condition necessitates a more integrated approach to management.
Many studies have suggested risk factor modification be incorporated as the fourth pillar of
AF management along with anticoagulation, rhythm control, and rate control [6–8]. Exercise
of regular moderate intensity, as a part of risk factor management of AF, not only improves
underlying conditions related to atherosclerotic cardiovascular disease (CVD) but has been
established to provide benefit for AF-related outcomes, including symptoms, incidence, recur-
rence, burden of AF, and quality of life [9–12]. Though the link between exercise and AF-
related outcomes has been supported by substantial evidence, benefits in cardiovascular mor-
bidities led by exercise in AF patients are less likely to be offered. The majority of deaths in AF
patients are cardiovascular in origin [13,14], thus emphasizing that optimal management of
underlying heart disease should be a part of the holistic approach to AF care [15].
Given the paucity of information about cardiovascular outcomes related to exercise habit
change after a new diagnosis of AF, we aimed to investigate the association between exercise
habits after a new AF diagnosis and the risk of ischemic stroke, HF, and all-cause death.
Methods
Data source and study population
We defined a population-based cohort from the National Health Information Database
(NHID), which incorporates all data from the National Health Insurance Service and covers
the entire population of the Republic of Korea (hereafter denoted as Korea). NHID is only
accessible online at designated analysis centers, with formal payment according to the period
of browsing and analyzing the data and applying strict regulations regarding data release
(https://nhiss.nhis.or.kr/). All insured adults are eligible for a biennially conducted general
health examination, and examination reports—including demographic variables, self-ques-
tionnaire survey, clinical laboratory values, inpatient and outpatient usage, prescription rec-
ords, income-based insurance contributions, and date of death—are available from NHID
[16,17]. The institutional review board at Seoul National University Hospital (E-2001-111-
1096) authorized this study. This study is reported as per the Strengthening the Reporting of
Observational Studies in Epidemiology (STROBE) guideline (S1 STROBE Checklist). The sta-
tistical analysis plan was not prespecified. However, the analysis was performed with a priori–
defined outcomes and covariates that were validated based on our previous publications before
analysis [18,19].
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We identified 523,174 patients newly diagnosed with AF between January 1, 2010, and
December 31, 2016, and excluded patients with valvular AF or age under 20 years. Among the
remaining patients, 132,741 patients who had data from 2 consecutive health examinations
within 2 years before and after AF diagnosis were analyzed. Since we evaluated de novo inci-
dence of ischemic stroke and HF after AF diagnosis, patients with prior recorded history of
ischemic stroke or HF before the index date (health examination date after AF diagnosis) were
excluded. Finally, 66,692 patients with AF were included in the analysis (Fig 1A).
Exercise evaluation
The individuals self-reported intensity and frequency of exercise via a questionnaire about life-
style behaviors at the serial health examinations before and after AF diagnosis. The survey
structure used for exercise evaluation was adopted and modified from the International Physi-
cal Activity Questionnaire (IPAQ), which was developed by the World Health Organization
(WHO); both the reliability and validity of this short-form survey were reported in previous
studies [20–23]. The questionnaire section on exercise was composed of 3 questions asking
about the frequency (days per week) of light, moderate, and vigorous exercise during a recent
week, i.e., the frequency of (i) light intensity exercise (e.g., walking slowly or sweeping carpets)
for more than 30 min, (ii) moderate intensity exercise (e.g., brisk-pace walking, tennis doubles,
or bicycling leisurely) for more than 30 min, and (iii) vigorous intensity exercise (e.g., running,
climbing, fast cycling, or aerobics) for more than 20 min. Exercise “Yes” was defined as per-
forming moderate intensity exercise for more than 30 min or vigorous intensity exercise for
more than 20 min, at least once a week. Exercise “No” was defined as not engaging in any
moderate or vigorous intensity exercise, regardless of any amount of light intensity exercise.
By comparing categorization of exercise status at the health examinations before and after AF
diagnosis, the study population was divided into 4 groups: persistent non-exercisers (No to
No), new exercisers (No to Yes), exercise dropouts (Yes to No), and exercise maintainers (Yes
Fig 1. Selection and categorization of the study population. (A) Selection of study population from the National Health Insurance Service. (B) Categorization of study
population according to the change of exercise status and overall scheme of study, including clinical outcomes. AF, atrial fibrillation; CHF, congestive heart failure.
https://doi.org/10.1371/journal.pmed.1003659.g001
PLOS MEDICINE Exercise habits and the cardiovascular outcomes in patients with incident atrial fibrillation
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1003659 June 8, 2021 4 / 19
to Yes). Fig 1B summarizes our study’s overall configuration and the selection of the popula-
tion included in the analysis.
To evaluate whether there exists an optimal exercise amount related to the best cardiovascu-
lar outcomes, we analyzed the hazards of cardiovascular morbidities according to stratified
energy expenditure. This analysis was performed in the new exerciser (No to Yes) group to
measure the influence of exercise introduction by isolating other healthy confounders that
might contribute to the maintenance of exercise. Energy expenditure denotes the “minimum”
amount of energy consumption calculated from a self-reported survey question that asks the
frequency of each intensity of exercise as a unit of least duration. To calculate energy expendi-
ture, we rated light, moderate, and vigorous intensity exercise as 2.9, 4.0, and 7.0 metabolic
equivalents of task (METs), respectively [24]. The total energy expenditure level—the summa-
tion of multiplying 2.9, 4.0, and 7.0 METs by frequency of light, moderate, and vigorous exer-
cise together with minimum duration—was stratified into<500, 500–999, 1,000–1,499, and
�1,500 MET-min/wk in an explorative way.
Covariates, follow-up, and clinical outcomes
Demographics, comorbidities (hypertension, diabetes mellitus, dyslipidemia, MI, peripheral
artery disease [PAD], chronic obstructive pulmonary disease [COPD], cancer, and chronic
kidney disease [CKD]), CHA2DS2-VASc score, medications, laboratory results, anthropo-
metric measurements, responses to the self-reported questionnaire conducted at the health
examination after AF diagnosis (index date), and income-based insurance contributions
were retrieved to analyze the baseline characteristics of individuals. To evaluate the relation-
ship between exercise habit change and cardiovascular outcomes, we determined incident
ischemic stroke and HF using International Classification of Diseases–10th Revision, Clini-
cal Modification (ICD-10-CM) codes in inpatient and outpatient records. The date of death,
and ICD-10-CM code recorded for the death, was obtained from NHID and used to investi-
gate all-cause death. We defined a major cardiovascular death as a death from the most fre-
quent 4 major specific diseases that belong to diseases of the circulatory system (I codes in
the ICD-10 system), and that most often are the cause of death among Korean AF patients:
cerebral infarction (I63), acute MI (I21), sequelae of cerebrovascular disease (I69), and HF
(I50) [14].
The follow-up period was defined as the time from the index date to the first occurrence of
ischemic stroke, HF, or death or December 31, 2017, whichever came first. Detailed definitions
of comorbidities and study outcomes are provided in S1 Table [2,25,26].
Statistics
Continuous variables are reported as mean ± standard deviation, and categorical variables are
reported as number (percentage). We performed inverse probability of treatment weighting
(IPTW) using propensity scores derived from all the baseline covariates including demograph-
ics, comorbidities, anthropometric measures, lifestyle behaviors, medications, and income sta-
tus to balance the weights across the 4 study groups. Maximum absolute standardized
difference (ASD) < 0.1 (10%) was evaluated as a negligible difference in the baseline covariates
between the study groups [27,28]. After IPTW, the weighted incidence rates of ischemic
stroke, HF, and all-cause death were computed by dividing each weighted event number by
the total follow-up duration and presented as per 1,000 person-years (PY). The risks of the out-
comes were computed by weighted Cox proportional hazards models with IPTW.
To compute the most optimal exercise amount for the best cardiovascular outcomes, we
defined the persistent non-exerciser category (No to No) as the reference group and computed
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a multivariable-adjusted Cox proportional hazards model with 95% confidence intervals (CIs);
model 1 was adjusted for age and sex, and model 2 was adjusted for body mass index (BMI),
hypertension, diabetes mellitus, dyslipidemia, previous MI, PAD, COPD, cancer, CKD,
CHA2DS2-VASc score, use of oral anticoagulation, use of antiplatelet agent, use of statin,
smoking, heavy drinking, and income level in addition to the variables in model 1. All analyses
were 2-tailed, and p-values < 0.05 were considered statistically significant. Data collection and
statistical analysis were performed using SAS version 9.4 (SAS Institute, Cary, NC) from Janu-
ary 2020 to September 2020.
Subgroup and sensitivity analyses
We performed subgroup analyses of the primary outcomes according to sex, age (<65, 65 to
<75, and�75 years), and CHA2DS2-VASc score (<3 and�3). The p-value for the interaction
was estimated to assess the consistency of patterns in the main results among subgroups.
To verify our results’ robustness, we performed sensitivity analyses by multivariable Cox
proportional hazards models. Model 1 was adjusted for age and sex, and model 2 was adjusted
for body measures, comorbidities, CHA2DS2-VASc score, medications, lifestyle behaviors, and
income level in addition to the variables in model 1. Two analyses were performed in response
to suggestions from peer review. We further evaluated the risk of the primary outcomes con-
sidering comorbidities or frailty using the Charlson Comorbidity Index (CCI), in addition to
computing model 2 to adjust for confounding factors that might lead to a change in exercise
status. The optimal amount of exercise was also analyzed in the exercise maintainer (Yes to




Of the total 66,692 patients with AF, the mean age was 59.5 ± 12.4 years, and 42,410 (63.6%)
were men. Comparison between the final study population and the excluded patients, most of
whom were excluded due to unavailable health examination data within 2 years both before
and after AF diagnosis, is summarized in S2 Table. Patients who received 0 or only 1 health
examination were older, were more likely to be female, had more prevalent comorbidities, and
had higher CHA2DS2-VASc scores than those with 2 health examinations.
The final study population consisted of 4 categories: persistent non-exercisers (n = 20,354,
30.5%), new exercisers (n = 11,874, 17.8%), exercise dropouts (n = 11,630, 17.4%), and exercise
maintainers (n = 22,834, 34.2%). The baseline characteristics of each group are shown in
Table 1. New exerciser and exercise maintainer groups tended to be younger, male-predomi-
nant, and less affected with comorbidities (especially PAD, COPD, and CKD), and to have
lower CHA2DS2-VASc scores and healthier lifestyle behaviors. We evaluated the differences
and balances among multiple groups using the maximum ASDs of all baseline covariates,
using a threshold of 0.1 to indicate imbalance. All of the covariates were well balanced after
IPTW (ASDs� 0.1). The multiple comparisons of covariates and the analysis of degrees of bal-
ance achievement between the 4 study groups were performed by calculating ASD (presented
in S3 Table).
The mean period from the health examination before AF diagnosis (first examination) to
the date of AF diagnosis was 1.1 ± 0.5 years, and from AF diagnosis to the health examination
after AF diagnosis (second examination) was 0.9 ± 0.5 years. Overall, the time between the 2
consecutive biennial health examinations was 2.0 ± 0.5 years.
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Change in exercise status and ischemic stroke, HF, and all-cause death
Mean follow-up durations for ischemic stroke, HF, and all-cause death were 3.4 ± 2.0,
3.0 ± 2.0, and 3.4 ± 1.9 years, respectively. Table 2 provides the weighted event numbers,
weighted incidence rates (per 1,000 PY), and weighted hazard ratios (HRs) of ischemic stroke,
HF, and all-cause death after IPTW.
Performing exercise any time before or after AF diagnosis was related to a lower risk of
mortality compared to those without exercise: the HR (95% CI) was 0.82 (0.73–0.91) for new
exercisers, 0.83 (0.74–0.93) for exercise dropouts and 0.61 (0.55–0.67) for exercise maintainers
(p< 0.001).
Initiating and maintaining exercise after AF diagnosis was associated with a lower risk of HF
compared to the persistent non-exerciser group: the HR (95% CI) was 0.95 (0.90–0.99) for the
new exerciser group and 0.92 (0.88–0.96) for the exercise maintainer group (p< 0.001). How-
ever, the exercise dropouts exhibited a similar risk of HF as the persistent non-exerciser group.
For ischemic stroke, participating in exercise was associated with 10%–14% lower risk com-
pared to the persistent non-exerciser group, but the precision in the estimates of HRs was sta-
tistically insignificant: the HR (95% CI) was 0.90 (0.79–1.03) for the new exerciser group and
0.86 (0.77–0.96) for the exercise maintainer group (p = 0.057). The weighted incidence rates
and risks of cardiovascular outcomes according to the change of exercise status are illustrated
in Fig 2.
Since the effect size of lowered estimates of HRs in all-cause death was larger than that of
ischemic stroke and HF, we investigated whether the lower risk of all-cause death was
Table 2. Hazard ratios with 95% confidence intervals for ischemic stroke, heart failure, and all-cause death









HR� (95% CI) or p-
value
Ischemic stroke
Persistent non-exercisers 20,354 633.22 9.13 1 (Ref.)
New exercisers 11,874 331.35 8.25 0.90 (0.79–1.03)
Exercise dropouts 11,630 323.73 8.15 0.89 (0.78–1.02)
Exercise maintainers 22,834 597.22 7.87 0.86 (0.77–0.96)
p = 0.057
Heart failure
Persistent non-exercisers 20,354 4,132.32 66.51 1 (Ref.)
New exercisers 11,874 2,279.61 62.95 0.95 (0.90–0.99)
Exercise dropouts 11,630 2,368.37 66.53 1 (0.95–1.05)
Exercise maintainers 22,834 4,201.33 61.32 0.92 (0.88–0.96)
p< 0.001
All-cause death
Persistent non-exercisers 20,354 981.20 13.87 1 (Ref.)
New exercisers 11,874 462.96 11.32 0.82 (0.73–0.91)
Exercise dropouts 11,630 465.04 11.49 0.83 (0.74–0.93)
Exercise maintainers 22,834 651.07 8.42 0.61 (0.55–0.67)
p< 0.001
p-Values were evaluated by the likelihood ratio test.
HR, hazard ratio; IR, incidence rate; PY, person-years.
�Weighted event numbers and weighted IRs were computed after inverse probability of treatment weighting (IPTW).
The HRs were computed by weighted Cox proportional hazards models with IPTW.
https://doi.org/10.1371/journal.pmed.1003659.t002
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indirectly attributable to the unadjusted confounders such as comorbidities or frailty, rather
than possible beneficial effects of exercise. The risk of death from major cardiovascular events
(major cardiovascular death) was lower in the exercise maintainers (HR 0.66, 95% CI 0.49–
0.90, p = 0.040) compared to the persistent non-exercisers. Both the new exercisers (HR 0.74,
95% CI 0.52–1.06) and the exercise dropouts (HR 0.71, 95% CI 0.49–1.02) tended to show a
lower HR without statistical significance, which might be due to low event numbers (S4
Table). However, a lower risk of major cardiovascular death in the exercise maintainer group
and lower estimates of HRs in the new exerciser and the exercise dropout groups were consis-
tent with the positive risk benefits in all-cause death (p = 0.040).
The relationship between energy expenditure and the risk of cardiovascular
outcomes
Multivariable-adjusted Cox proportional hazards analysis of ischemic stroke, HF, and all-
cause death in the new exerciser group (No to Yes) according to the stratified amount of exer-
cise is presented in S5 Table. Exercising 1,000–1,499 MET-min/wk (1,208.1 ± 159.7 MET-
min/wk) was consistently associated with a lower risk of adverse cardiovascular outcomes
(adjusted HR 0.77, 95% CI 0.60–0.99, p = 0.229, for ischemic stroke; adjusted HR 0.90, 95% CI
0.82–0.99, p = 0.166, for HF) and all-cause death (adjusted HR 0.68, 95% CI 0.54–0.84, p =
0.002) compared to the persistent non-exerciser group. Lower risks of ischemic stroke, HF,
and all-cause death were correlated with energy expenditure increment, but the associations
became attenuated in the group with exercise amount at or above 1,500 MET-min/wk (Fig 3).
Subgroup and sensitivity analyses
Subgroup analysis was performed by sex, age, and CHA2DS2-VASc score (S6–S8 Tables). For
ischemic stroke, there were no significant statistical interactions for sex, age, and CHA2DS2-
VASc score. The incidence of HF showed an interaction with age, potentially due to an
Fig 2. Hazard ratios with 95% confidence intervals for ischemic stroke, heart failure, and all-cause death according to the change of exercise status. The bars
denote weighted incidence rates, the dots denote hazard ratios, and the whiskers denote 95% confidence intervals computed by weighted Cox proportional hazards
models with inverse probability of treatment weighting.
https://doi.org/10.1371/journal.pmed.1003659.g002
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augmented lower risk of HF in the exercise maintainer group among those aged 75 years and
older (p for interaction = 0.019). The risk of all-cause death presented an interaction with sex
that might be explained by greater benefits of exercise in male patients (p for
interaction = 0.048).
Sensitivity analyses validating the risks of primary outcomes according to the change of
exercise habits estimated by multivariable-adjusted Cox proportional hazards models are pre-
sented in S9 Table. The risks of ischemic stroke, HF, and all-cause death adjusted by model 2
and CCI were consistent with those in the main analysis. Indeed, S1 Fig shows various adjust-
ment models and corresponding HRs, showing consistent outcomes irrespective of the vari-
ables incorporated in the adjustments. The HRs were only different in subtle ways between the
models. Another sensitivity analysis verifying whether there exists a dose–response relation-
ship between energy expenditure and the risk of cardiovascular outcomes was performed in
the exercise maintainer group (Yes to Yes) and is presented in S10 Table. The levels of energy
expenditure showing the lowest estimates of HRs were all different across ischemic stroke, HF,
and all-cause death, unlike the consistent level in the new exerciser group (No to Yes).
Discussion
In this nationwide population-based cohort study, our principal findings are as follows. First,
initiation and maintenance of exercise after AF diagnosis were associated with a significantly
lower risk for HF and all-cause death. Interestingly, exercise dropout was associated with a
lower risk of all-cause death as well. Second, the estimates of HRs of ischemic stroke were
lower in AF patients with any lifetime experience of exercise before and after AF diagnosis,
though the association was statistically insignificant. Third, performing exercise at an energy
expenditure level of 1,000–1,499 MET-min/wk (moderate intensity exercise 170–240 min/wk
or vigorous intensity exercise 140–210 min/wk) was consistently associated with lower risks of
ischemic stroke, HF, and all-cause death in the new exerciser group. This estimated range of
energy expenditure is in accord with the previously recommended volume of exercise in AF
Fig 3. Hazard ratios with 95% confidence intervals for ischemic stroke, heart failure, and all-cause death in the new exerciser group (No to Yes) according to
energy expenditure (MET-min/wk). The bars denote weighted incidence rates, the dots denote hazard ratios, and the whiskers denote 95% confidence intervals
computed by weighted Cox proportional hazards models with inverse probability of treatment weighting. MET, metabolic equivalent of task.
https://doi.org/10.1371/journal.pmed.1003659.g003
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patients [11], yet slightly higher than the minimum leisure-time physical activity suggested for
the general population [29].
AF is associated with an increased risk of death and other cardiovascular events [4], which
confers a major healthcare burden. A recent cohort study in men demonstrated the inverse asso-
ciation between fitness and mortality [30,31], and the same relationship was reproduced in
patients with AF. For example, in the HUNT3 study, physical activity levels in AF patients
showed an inverse correlation with risks of all-cause and CVD mortality, as well as the risk of
CVD morbidity [32]. Also, the EORP-AF registry reported a lower risk of all-cause death in AF
patients engaging in regular exercise at 1-year follow-up and showed an inverse association of
cardiovascular outcomes with exercise levels [33]. In addition to there being a mortality benefit of
anticoagulation therapy in AF patients [34], our results provide evidence of a mortality benefit of
exercise in AF patients as a part of a holistic approach to AF care [15]. Moreover, the benefit of
exercise with respect to all-cause death was robust even after evaluating the association by another
statistical method and adjusting the model, including as many covariates as possible. Also, the
risk benefit for major cardiovascular death, using the 4 most frequent major CVDs explaining
deaths of AF patients in Korea [13,14,35–37], presented a pattern consistent with that of all-cause
death; thus, the lowered risk of all-cause death might come from the positive effects of exercise.
HF is closely linked to AF by sharing common predisposing conditions, and the coexistence of
AF and HF is associated with adverse prognosis [38]. Newly diagnosed AF increases the risk of
HF, and individuals with concomitant AF and HF are at a greater risk of all-cause mortality and
have higher hospital admission rates [39–41]. Exercise is known to have a protective effect in pre-
venting HF and is beneficial to patients with already established HF as well [42]. Also, moderate
and high exercise levels are associated with a lower risk of HF regardless of BMI in the general
population [43]. Possible mechanisms contributing to the favorable result regarding long-term HF
risk include the reduction of subclinical myocardial damage and abnormal left ventricle remodel-
ing [44,45]. Our study extends the previous findings of exercise in HF patients to patients with AF,
whereby those with regular moderate exercise after AF diagnosis showed 5% to 8% lower risk of
HF development. Interestingly, the individuals 75 years and older showed even greater benefits of
exercise for the risk of HF, suggesting that assessment of daily physical activities and recommenda-
tions on exercise are still important for elderly individuals with newly diagnosed AF.
On the other hand, we found that the association between exercise and the risk of stroke
was not statistically significant. Increased physical activity lowers stroke risk in the general
population [46], but this association was conflicting in patients with AF among previous publi-
cations. The HUNT3 study showed an insignificantly lower risk of stroke among patients with
AF fulfilling physical activity guidelines, consistent with our study [32]. Meanwhile, another
study of cross-country skiers demonstrated that endurance exercise in AF patients is associated
with a lower risk of stroke [47]. Moreover, an inverse association between cardiorespiratory
fitness and the risk of stroke in patients with AF also has been reported [48]. The relatively low
event rate of ischemic stroke compared to HF and all-cause death in our study might attribute
to the lack of statistical power; thus, further research needs to address the association between
exercise and the risk of ischemic stroke.
The amount of exercise and the risk of AF show a J-shaped relationship; for example,
endurance exercise is known to increase the risk of AF [49]. However, no current data provide
the specific intensity and amount of exercise that could be recommended to AF patients to
benefit cardiovascular outcomes. We not only showed an association between exercise habit
change and the clinical outcomes (ischemic stroke, HF, and mortality) in AF patients, we tried
to suggest an appropriate amount of exercise. We found that exercising 1,000–1,499 MET-
min/wk was associated with lower event rates for stroke, HF, and mortality in the new exer-
ciser group. This level of energy expenditure corresponds to performing moderate intensity
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exercise 170–240 min/wk and is comparable to the amount recommended to adults aged 18–64
years with or without chronic conditions: 150–300 min/wk of moderate intensity aerobic physi-
cal activity, for substantial health benefits according to WHO guidelines on physical activity
and sedentary behavior [50]. Interestingly, the association appeared to be attenuated in the
range of exercise�1,500 MET-min/wk rather than persistently showing a direct inverse correla-
tion. The mechanisms for intensive exercise to increase the risk of AF are diverse, including
changes in autonomic activation [51,52], atrial dilatation [53,54], fibrosis, and inflammation
[55,56]. Similar physiological changes would explain the attenuated risk benefit in AF patients
with exercise level� 1,500 MET-min/wk across cardiovascular outcomes, and particularly in
all-cause death. However, considering the wide 95% CIs in patients with�1500 MET-min/wk,
the small patient numbers in this group might be underpowered. Besides, the optimal amount
of exercise in the exercise maintainer group showed different energy levels having the lowest
estimates of HRs for each cardiovascular outcome. We assume that accumulated and prolonged
exercise would have influenced the clinical outcomes with different magnitudes of impacts.
Taking the evidence together, this exercise dose–response relationship should be interpreted
cautiously due to several limitations, including the explorative stratification of exercise and the
lack of statistical power. Our quantitative analysis could give a clue for future prospective studies
investigating the optimal intensity and amount of exercise in arrhythmia patients.
Exercise has been widely documented to modify potential contributors to AF, such as obe-
sity, hypertension, and diabetes, by improving weight, glucose and lipid control, and endothe-
lial function, and lowering resting heart rate and blood pressure [57–59]. Not only can risk
factors for AF but also cardiac structure and function be modified by exercise. For example,
Malmo et al. [11] found that, in patients with AF, the exercise group was associated with
improved left atrial and ventricular function indices. These mechanisms might contribute to
the noticeably lower risk of HF and all-cause mortality (and possibly a lower HR for ischemic
stroke) in our study in the new exerciser and exercise maintainer groups compared to the per-
sistent non-exerciser group. Also, arrhythmogenic risk factors and cardiac alterations through
exercise might exert continued advantageous effects even in the exercise dropout group, result-
ing in lower mortality. Of note, we categorized the study population by the change of exercise
status after diagnosis of AF; thus, the link between exercise and cardiovascular outcomes could
be analyzed according to new exerciser or exercise maintainer status, which could differentiate
the benefit of exercise per se from an accumulated gain of exercise and other healthy con-
founders that enable maintenance of exercise.
A recent large prospective study quantifying daily physical activity among individuals using
electronic wearable devices found that individuals with AF engage in significantly less average
daily physical activity than those without AF [60]. As we have demonstrated, the influence of
exercise mitigated the risks of HF, all-cause death, and probably ischemic stroke in patients
with AF, and thus, exercise should be an essential component of nonpharmacological manage-
ment of AF. Indeed, exercise is part of the lifestyle recommendations in the ABC (Atrial fibril-
lation Better Care) pathway of holistic or integrated AF management and has been shown in
the prospective mAFA-II randomized trial to improve overall outcomes [61]. The ABC path-
way refers to the following: “A” for avoid stroke/anticoagulation, “B” for better symptom man-
agement, and “C” for cardiovascular and comorbidity management, including lifestyle
changes [15].
Limitations
Several limitations are evident in our study. First, the self-reported nature of the health exami-
nation survey asking about exercise frequency would be influenced by recall bias. Second, the
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minimum energy expenditure estimated from the 3 questions is limited in its ability to reflect
the actual amount of exact exercise level; it would not be possible to precisely quantify exercise
(e.g., using pedometers) in this population-based study. Due to limited data about exact exer-
cise volume from the questionnaire, the relationship between endurance exercise and cardio-
vascular outcomes could not be evaluated. Third, unavailable confounding factors might not
be fully adjusted for. Fourth, the type and burden of AF were not available; thus, the contribu-
tion of these factors to the outcomes could not be analyzed. Fifth, potential change in exercise
status from the index date to the end of follow-up might introduce bias in the associations.
Sixth, the study was conducted in an Asian population; therefore, physiological and cultural
differences in exercise behavior or biological response to exercise might limit the external gen-
eralizability to other ethnic groups. Seventh, the inclusion of only patients who had 2 consecu-
tive health examinations before and after AF diagnosis would cause some selection bias. Our
results would have limited evidence in those who could not receive health screening due to
underlying diseases; thus, the results should be interpreted and applied cautiously to the gen-
eral AF population. Lastly, this was not a randomized controlled study, and causality and the
direct mechanistic link between exercise and cardiovascular outcomes cannot be determined.
However, there may be an ethical issue with study designs restricting exercise (or stopping any
exercise), which would make it difficult to include as part of a randomized controlled study.
Instead, our data from this large population-based research provide potential evidence for the
beneficial effects of exercise on clinical outcomes as part of holistic AF management.
Conclusion
In this nationwide population-based cohort study, initiating or continuing regular exercise
after AF diagnosis was associated with lower risks of HF and mortality. Regular moderate exer-
cise 170–240 min/wk might be an optimal amount for deriving maximal cardiovascular bene-
fits in patients who initiate exercise after AF diagnosis, but further prospective research needs
to delineate the specific optimal energy expenditure. Timely encouragement of exercise to
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